X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with Nestle - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs NESTLE - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

NESTLE 
   Change

Nestle India is a 100-year old and second largest FMCG company dominating the noodle (Maggi) and the hot beverage (Nescafe) categories. Milk products & nutrition is the largest segment with a 44% sales share. This is followed by prepared dishes & coo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER NESTLE GSK CONSUMER/
NESTLE
 
P/E (TTM) x 36.7 64.7 56.7% View Chart
P/BV x 9.0 29.8 30.1% View Chart
Dividend Yield % 1.0 0.8 124.2%  

Financials

 GSK CONSUMER   NESTLE
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
NESTLE
Dec-17
GSK CONSUMER/
NESTLE
5-Yr Chart
Click to enlarge
High Rs6,7938,001 84.9%   
Low Rs4,9195,800 84.8%   
Sales per share (Unadj.) Rs1,026.31,038.1 98.9%  
Earnings per share (Unadj.) Rs166.5127.1 131.0%  
Cash flow per share (Unadj.) Rs181.8162.6 111.8%  
Dividends per share (Unadj.) Rs75.0086.00 87.2%  
Dividend yield (eoy) %1.31.2 102.8%  
Book value per share (Unadj.) Rs828.6354.8 233.6%  
Shares outstanding (eoy) m42.0696.42 43.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.76.6 85.8%   
Avg P/E ratio x35.254.3 64.8%  
P/CF ratio (eoy) x32.242.4 75.9%  
Price / Book Value ratio x7.119.5 36.3%  
Dividend payout %45.167.7 66.6%   
Avg Mkt Cap Rs m246,284665,346 37.0%   
No. of employees `0004.07.5 52.9%   
Total wages/salary Rs m5,27710,175 51.9%   
Avg. sales/employee Rs Th10,837.313,298.2 81.5%   
Avg. wages/employee Rs Th1,325.01,351.7 98.0%   
Avg. net profit/employee Rs Th1,757.71,627.7 108.0%   
INCOME DATA
Net Sales Rs m43,165100,096 43.1%  
Other income Rs m2,5741,769 145.5%   
Total revenues Rs m45,739101,865 44.9%   
Gross profit Rs m8,83420,965 42.1%  
Depreciation Rs m6443,423 18.8%   
Interest Rs m20919 2.2%   
Profit before tax Rs m10,74418,393 58.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,7436,141 60.9%   
Profit after tax Rs m7,00112,252 57.1%  
Gross profit margin %20.520.9 97.7%  
Effective tax rate %34.833.4 104.3%   
Net profit margin %16.212.2 132.5%  
BALANCE SHEET DATA
Current assets Rs m45,62039,374 115.9%   
Current liabilities Rs m17,42614,927 116.7%   
Net working cap to sales %65.324.4 267.4%  
Current ratio x2.62.6 99.2%  
Inventory Days Days3533 105.2%  
Debtors Days Days243 726.5%  
Net fixed assets Rs m5,13827,103 19.0%   
Share capital Rs m421964 43.6%   
"Free" reserves Rs m34,43133,242 103.6%   
Net worth Rs m34,85134,206 101.9%   
Long term debt Rs m0351 0.0%   
Total assets Rs m54,12773,626 73.5%  
Interest coverage x530.221.0 2,523.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.81.4 58.7%   
Return on assets %13.017.9 72.5%  
Return on equity %20.135.8 56.1%  
Return on capital %30.955.9 55.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,0146,627 45.5%   
Fx outflow Rs m18614,291 1.3%   
Net fx Rs m2,828-7,664 -36.9%   
CASH FLOW
From Operations Rs m7,23018,178 39.8%  
From Investments Rs m-4,465-1,306 342.0%  
From Financial Activity Rs m-3,634-9,966 36.5%  
Net Cashflow Rs m-8686,906 -12.6%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 72.5 62.8 115.4%  
Indian inst/Mut Fund % 0.8 4.5 17.8%  
FIIs % 12.0 12.5 96.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 20.3 72.9%  
Shareholders   26,457 62,821 42.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   SANWARIA AGRO OILS  AVANTI FEEDS  SAVITA OIL TECH.  GUJ.AMB.EXP.  VST INDUSTRIES  

Compare GSK CONSUMER With:   NESTLE (Switz.)  TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views on News

NESTLE 2016-17 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of NESTLE for 2016-17. It includes a full income statement, balance sheet and cash flow analysis of NESTLE. Also includes updates on the valuation of NESTLE.

NESTLE Announces Quarterly Results (2QFY19); Net Profit Up 30.0% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, NESTLE has posted a net profit of Rs 4 bn (up 30.0% YoY). Sales on the other hand came in at Rs 29 bn (up 16.9% YoY). Read on for a complete analysis of NESTLE's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY19); Net Profit Up 43.2% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, GSK CONSUMER has posted a net profit of Rs 3 bn (up 43.2% YoY). Sales on the other hand came in at Rs 13 bn (up 14.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

NESTLE 2016-17 Annual Report Analysis (Annual Result Update)

Sep 17, 2018 | Updated on Sep 17, 2018

Here's an analysis of the annual report of NESTLE for 2016-17. It includes a full income statement, balance sheet and cash flow analysis of NESTLE. Also includes updates on the valuation of NESTLE.

GSK CONSUMER Announces Quarterly Results (1QFY19); Net Profit Up 51.6% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 51.6% YoY). Sales on the other hand came in at Rs 11 bn (up 5.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Feb 15, 2019 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS